Management of Pregnancy-Associated Thrombotic Thrombocytopenia Purpura
Authors:
Open Access
- 19 December 2012
- journal article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology Reports
- Vol. 03 (01) , 045-050
Abstract
Thrombotic thrombocytopenia purpura (TTP) is an infrequent but serious disease. Pregnancy is a known risk factor for presentation or relapse of TTP. Difficulties in differentiating TTP from preeclampsia/HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome, and current treatment recommendations are discussed in this case report. A woman with previously treated and stable TTP had a relapse at 36 weeks' gestation. Careful surveillance led to an early diagnosis. Severe disease in the peripartum period was treated successfully with cryosupernatant plasma-based plasmapheresis and platelet transfusion, with good maternal and neonatal outcomes. Cryosupernatant plasma is a viable alternative to fresh frozen plasma for plasmapheresis for TTP and may offer some therapeutic and logistical advantages. Platelet transfusion can be undertaken safely if needed to prevent or treat significant hemorrhage.Keywords
This publication has 26 references indexed in Scilit:
- ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancyBritish Journal of Haematology, 2011
- Clinical study on five cases of thrombotic thrombocytopenic purpura complicating pregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraCochrane Database of Systematic Reviews, 2009
- Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpuraBlood Coagulation & Fibrinolysis, 2006
- Treatment of thrombotic thrombocytopenic purpuraVox Sanguinis, 2006
- Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura–hemolytic uremic syndromeTransfusion, 2004
- Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)Blood, 2002
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeBlood, 2002
- Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1996
- Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpuraAmerican Journal of Hematology, 1990